carbamazepine has been researched along with Cerebellar Ataxia in 10 studies
Carbamazepine: A dibenzazepine that acts as a sodium channel blocker. It is used as an anticonvulsant for the treatment of grand mal and psychomotor or focal SEIZURES. It may also be used in the management of BIPOLAR DISORDER, and has analgesic properties.
carbamazepine : A dibenzoazepine that is 5H-dibenzo[b,f]azepine carrying a carbamoyl substituent at the azepine nitrogen, used as an anticonvulsant.
Cerebellar Ataxia: Incoordination of voluntary movements that occur as a manifestation of CEREBELLAR DISEASES. Characteristic features include a tendency for limb movements to overshoot or undershoot a target (dysmetria), a tremor that occurs during attempted movements (intention TREMOR), impaired force and rhythm of diadochokinesis (rapidly alternating movements), and GAIT ATAXIA. (From Adams et al., Principles of Neurology, 6th ed, p90)
| Excerpt | Relevance | Reference |
|---|---|---|
| " Since gaze-evoked nystagmus, dizziness, and ataxia are some of the typical adverse effects (AEs) of the dose-dependent toxicity of carbamazepine, preexisting CA could possible explain in part the interindividual variation in the tolerance of high serum concentrations of carbamazepine." | 7.69 | Cerebellar atrophy decreases the threshold of carbamazepine toxicity in patients with chronic focal epilepsy. ( May, TW; Rohde, M; Schmidt, RC; Schütz, M; Specht, U; Wagner, V; Wolf, P, 1997) |
| " Reversible dystonia may occasionally be precipitated by phenytoin or carbamazepine; asterixis by phenytoin, barbiturates or carbamazepine; and, more commonly, tremor by valproate." | 4.77 | Adverse neuropsychiatric effects of anticonvulsant drugs. ( Reynolds, EH; Trimble, MR, 1985) |
| " Since gaze-evoked nystagmus, dizziness, and ataxia are some of the typical adverse effects (AEs) of the dose-dependent toxicity of carbamazepine, preexisting CA could possible explain in part the interindividual variation in the tolerance of high serum concentrations of carbamazepine." | 3.69 | Cerebellar atrophy decreases the threshold of carbamazepine toxicity in patients with chronic focal epilepsy. ( May, TW; Rohde, M; Schmidt, RC; Schütz, M; Specht, U; Wagner, V; Wolf, P, 1997) |
| "Carbamazepine (CBZ) was found to be effective in most cases." | 2.61 | Epilepsy in patients with EAST syndrome caused by mutation in the KCNJ10. ( Albaradie, R; Alhazmi, R; Alkhaldi, H; Chaudhary, M; Housawi, Y; Mir, A, 2019) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (40.00) | 18.7374 |
| 1990's | 3 (30.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (20.00) | 24.3611 |
| 2020's | 1 (10.00) | 2.80 |
| Authors | Studies |
|---|---|
| Samson Osuntokun, O | 1 |
| Grace Akingboye, B | 1 |
| Olayiwola, G | 1 |
| Adekemi Abayomi, T | 1 |
| Oladele Ayoka, A | 1 |
| Mir, A | 1 |
| Chaudhary, M | 1 |
| Alkhaldi, H | 1 |
| Alhazmi, R | 1 |
| Albaradie, R | 1 |
| Housawi, Y | 1 |
| Wang, K | 1 |
| Xu, Z | 1 |
| Xiong, G | 1 |
| Benyan, L | 1 |
| Specht, U | 2 |
| Rohde, M | 2 |
| May, T | 1 |
| Schmidt, RC | 2 |
| Meencke, HJ | 1 |
| Wolf, P | 2 |
| Manto, MU | 1 |
| Jacquy, J | 1 |
| Hildebrand, J | 1 |
| May, TW | 1 |
| Wagner, V | 1 |
| Schütz, M | 1 |
| Goldhoorn, PB | 1 |
| Hofstee, N | 1 |
| Reynolds, EH | 1 |
| Trimble, MR | 1 |
| Ramsay, RE | 1 |
| Cendrowski, W | 1 |
3 reviews available for carbamazepine and Cerebellar Ataxia
| Article | Year |
|---|---|
Epilepsy in patients with EAST syndrome caused by mutation in the KCNJ10.
Topics: Anticonvulsants; Brain; Carbamazepine; Cerebellar Ataxia; Child; Child, Preschool; Epilepsy; Female; | 2019 |
Adverse neuropsychiatric effects of anticonvulsant drugs.
Topics: Animals; Anti-Anxiety Agents; Anticonvulsants; Barbiturates; Benzodiazepines; Biogenic Amines; Carba | 1985 |
Use of phenytoin and carbamazepine in treatment of epilepsy.
Topics: Anemia, Aplastic; Carbamazepine; Cerebellar Ataxia; Chemical and Drug Induced Liver Injury; Cognitio | 1986 |
7 other studies available for carbamazepine and Cerebellar Ataxia
| Article | Year |
|---|---|
The impairment of motor coordination following chronic carbamazepine-levetiracetam combination treatment with evidence of corticocerebellar toxicity in male Wistar rats.
Topics: Animals; Anticonvulsants; Ataxia; Carbamazepine; Cerebellar Ataxia; Cerebellum; Drug Therapy, Combin | 2021 |
Superficial siderosis of the central nervous system manifested with seizures.
Topics: Adult; Anticonvulsants; Carbamazepine; Central Nervous System; Cerebellar Ataxia; Cerebellum; Hearin | 2010 |
Cerebellar atrophy does not increase susceptibility to carbamazepine toxicity.
Topics: Adolescent; Adult; Atrophy; Carbamazepine; Cerebellar Ataxia; Cerebellum; Dose-Response Relationship | 1994 |
Cerebellar ataxia in upper limbs triggered by addition of carbamazepine to lithium treatment.
Topics: Antimanic Agents; Bipolar Disorder; Carbamazepine; Cerebellar Ataxia; Drug Interactions; Drug Therap | 1996 |
Cerebellar atrophy decreases the threshold of carbamazepine toxicity in patients with chronic focal epilepsy.
Topics: Adolescent; Adult; Anticonvulsants; Ataxia; Atrophy; Carbamazepine; Cerebellar Ataxia; Cerebellum; E | 1997 |
[Interaction between erythromycin and carbamazepine].
Topics: Carbamazepine; Cerebellar Ataxia; Drug Interactions; Drug Therapy, Combination; Erythromycin; Female | 1989 |
[Paroxysmal ataxia, tonic spasms and paroxysmal paralysis in multiple sclerosis].
Topics: Adrenocorticotropic Hormone; Adult; Body Temperature; Carbamazepine; Cerebellar Ataxia; Electroencep | 1971 |